Ray Dalio’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Sell |
8,943
-78,295
| -90% | -$9.84M | ﹤0.01% | 463 |
|
|
2025
Q1 | $9.65M | Sell |
87,238
-245,360
| -74% | -$27.1M | 0.04% | 265 |
|
|
2024
Q4 | $45.4M | Buy |
332,598
+197,412
| +146% | +$26.9M | 0.21% | 90 |
|
|
2024
Q3 | $15.6M | Buy |
135,186
+47,638
| +54% | +$5.49M | 0.09% | 192 |
|
|
2024
Q2 | $12.1M | Buy |
87,548
+64,397
| +278% | +$8.87M | 0.06% | 224 |
|
|
2024
Q1 | $3.19M | Sell |
23,151
-354
| -2% | -$48.8K | 0.02% | 432 |
|
|
2023
Q4 | $3.1M | Sell |
23,505
-31,490
| -57% | -$4.15M | 0.02% | 445 |
|
|
2023
Q3 | $6.19M | Sell |
54,995
-170
| -0.3% | -$19.1K | 0.04% | 314 |
|
|
2023
Q2 | $5.2M | Sell |
55,165
-4,045
| -7% | -$381K | 0.03% | 304 |
|
|
2023
Q1 | $5.99M | Buy |
+59,210
| New | +$5.99M | 0.04% | 281 |
|
|
2022
Q3 | – | Sell |
-6,503
| Closed | -$634K | – | 971 |
|
|
2022
Q2 | $634K | Buy |
6,503
+1,483
| +30% | +$145K | ﹤0.01% | 870 |
|
|
2022
Q1 | $471K | Buy |
5,020
+2,493
| +99% | +$234K | ﹤0.01% | 894 |
|
|
2021
Q4 | $215K | Sell |
2,527
-670
| -21% | -$57K | ﹤0.01% | 720 |
|
|
2021
Q3 | $307K | Sell |
3,197
-2,737
| -46% | -$263K | ﹤0.01% | 635 |
|
|
2021
Q2 | $577K | Buy |
+5,934
| New | +$577K | ﹤0.01% | 637 |
|